Global Tuberculosis Diagnostics and Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Tuberculosis Diagnostics and Treatment Market Overview

• 1.1 Product Overview and Scope of Tuberculosis Diagnostics and Treatment
• 1.2 Classification of Tuberculosis Diagnostics and Treatment by Types
  • 1.2.1 Global Tuberculosis Diagnostics and Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Skin Testing
  • 1.2.4 Laboratory Testing
• 1.3 Global Tuberculosis Diagnostics and Treatment Market by Application
  • 1.3.1 Global Tuberculosis Diagnostics and Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Tuberculosis Diagnostics and Treatment Market by Regions
  • 1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Tuberculosis Diagnostics and Treatment (2014-2024)

2 Manufacturers Profiles

• 2.1 Cepheid Inc
  • 2.1.1 Business Overview
  • 2.1.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Becton Dickinson
  • 2.2.1 Business Overview
  • 2.2.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Hain LifeSciences
  • 2.3.1 Business Overview
  • 2.3.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Abbott Laboratories
  • 2.4.1 Business Overview
  • 2.4.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Alere, Inc
  • 2.5.1 Business Overview
  • 2.5.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Roche AG
  • 2.6.1 Business Overview
  • 2.6.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Hologic Corporation
  • 2.7.1 Business Overview
  • 2.7.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 bioMerieux
  • 2.8.1 Business Overview
  • 2.8.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Sanofi
  • 2.9.1 Business Overview
  • 2.9.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 QIAGEN
  • 2.10.1 Business Overview
  • 2.10.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Akonni Biosystems, Inc.
  • 2.11.1 Business Overview
  • 2.11.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Epistem Holdings Plc
  • 2.12.1 Business Overview
  • 2.12.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Gen-Probe Inc.
  • 2.13.1 Business Overview
  • 2.13.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 EIKEN Chemical
  • 2.14.1 Business Overview
  • 2.14.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Thermo Fisher Scientific, Inc
  • 2.15.1 Business Overview
  • 2.15.2 Tuberculosis Diagnostics and Treatment Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Tuberculosis Diagnostics and Treatment Market Competition, by Players

• 3.1 Global Tuberculosis Diagnostics and Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Tuberculosis Diagnostics and Treatment Players Market Share
  • 3.2.2 Top 10 Tuberculosis Diagnostics and Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Tuberculosis Diagnostics and Treatment Market Size by Regions

• 4.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Regions
• 4.2 North America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

5 North America Tuberculosis Diagnostics and Treatment Revenue by Countries

• 5.1 North America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
• 5.2 USA Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

6 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries

• 6.1 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries

• 7.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
• 7.2 China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

8 South America Tuberculosis Diagnostics and Treatment Revenue by Countries

• 8.1 South America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Tuberculosis Diagnostics and Treatment by Countries

• 9.1 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)

10 Global Tuberculosis Diagnostics and Treatment Market Segment by Type

• 10.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Type (2019-2024)
• 10.3 Skin Testing Revenue Growth Rate (2014-2024)
• 10.4 Laboratory Testing Revenue Growth Rate (2014-2024)

11 Global Tuberculosis Diagnostics and Treatment Market Segment by Application

• 11.1 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Tuberculosis Diagnostics and Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2019-2024)

• 12.1 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2019-2024)
• 12.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology